已发表论文

USP34 的下调通过抑制 PRR11 来遏制胰腺癌细胞的生长和迁移

 

Authors Lin C, Xia J, Gu Z, Meng Y, Gao D, Wei S

Received 27 August 2019

Accepted for publication 10 January 2020

Published 18 February 2020 Volume 2020:13 Pages 1471—1480

DOI https://doi.org/10.2147/OTT.S228857

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Dr Leo Jen-Liang Su

Background: Pancreatic cancer (PC) is a highly lethal malignancy worldwide. Our previous study indicated that overexpression of USP34 could promote tumor growth in PC cells. Therefore, this study aimed to further investigate the role of USP34 during the tumorigenesis of PC.
Methods: The level of USP34 in PANC-1 and MiaPaCa-2 cells transfected with USP34-shRNAs was detected by RT-qPCR. Moreover, transwell migration and Annexin V/PI analysis were conducted to detect cell migration and apoptosis, respectively.
Results: In this study, downregulation of USP34 markedly inhibited proliferation and migration, and induced apoptosis in PANC-1 cells. Moreover, silencing of USP34 obviously downregulated the levels of PRR11 and p-p38 in PANC-1 cells. An in vivo study in nude mice bearing PANC-1 cell xenografts confirmed these results.
Conclusion: Downregulation of USP34 could inhibit proliferation and migration in PANC-1 cells via inhibiting PRR11, and inactivating p38 MAPK signaling. Therefore, USP34 might be a potential therapeutic target for the treatment of PC.
Keywords: pancreatic cancer, ubiquitin-specific protease USP34, proline-rich 11, apoptosis




Figure 2 Downregulation of USP34 inhibited the proliferation of PC cells via...